Ist Biohacking nur Spielerei für echte Technik-Geeks? Oder sind Biohacker die Early Adopter einer Technologie, die uns alle erreichen wird? Einer von ihnen ist Teemu Arina. Für ihn ist der Körper ein System, das verstanden und verbessert werden will. Im Kurz-Interview (Englisch) verrät er, was Biohacking ist und warum die Technologien auch für Pharmaunternehmen von Bedeutung sind.

Lysander Fuchs: Mr. Arina, why do you do what you do? What is your mission?

Teemu Arina: I see the human body as a complex system. Like any other system it can be probed, analyzed and understood. We use science to do just that. So, in the end, the core of what I do is to enable better living through science.

Lysander Fuchs: Biohacking might sound strange to people, who are new to this. What is biohacking?

Teemu Arina: Biohacking is the art and science of optimizing your body and mind for better performance. A Biohacker uses systems thinking, technology and biology to do that. First, we try to understand the body and mind with biometric wearables. Next, we intervene and optimize in a systemic manner with nutrition, exercise and other lifestyle changes.

Lysander Fuchs: What are biohacking technologies, that will be relevant for the general public in the next 1-2 years?

Teemu Arina: I believe when it comes to biohacking, we’ve only scratched the surface. There are already various tracking devices that can monitor different measurements like stress, recovery and metabolism. In the future we will use technology not only to monitor our body, but to actively change the body. In the future electroceuticals, nutrigenomics, stem cell therapies and synthetic biology will be increasingly important.

Lysander Fuchs: What are the implications for pharmaceutical companies?

Teemu Arina: The latest Gartner Report on Hype Cycle evaluates biohacking and Artificial Intelligence to be important emerging technologies to pay attention to.

Next to sick care, preventive healthcare will be a growing industry over the next few years.  Understanding and optimizing the body, which is at the core of biohacking, will enable people to do just that. In the future pharmaceutical companies can and should develop therapies aimed at preventing disease before it occurs.

Lysander Fuchs: What’s the future for biohacking? What possibilities lie ahead?

Teemu Arina: In the future we will be transcending what it means to be human. Science Fiction has written and shown a lot of the possibilities that lie ahead. Some of which seemed more like fiction are now becoming a science. The next industrial revolution will be a convergence between biological and technological intelligence.

Lysander Fuchs: Thank you, Mr. Arina, I am looking forward to hearing you speak more about this at our summit.

Save the Date

Save the Date: 6. coliquio Summit am 18. Juni 2020

Lust auf noch mehr Inspiration? Nächstes Jahr geht es weiter! Wenn Sie den coliquio Summit nicht verpassen wollen, dann lassen Sie sich jetzt schon vormerken.

Diese Beiträge könnten Sie auch interessieren

Hinterlassen Sie einen Kommentar
E-Mail-Adressen werden nicht veröffentlicht.

Ich möchte Benachrichtigungen erhalten bei weiteren Kommentaren.

Lysander Fuchs
Lysander Fuchs
ist Redakteur bei coliquio Insights und berichtet über aktuelle Marketing-Themen und ihre Relevanz für den Gesundheitsmarkt.